Microbiota Introduced to Germ-Free Rats Restores Vascular Contractility and Blood Pressure.


Journal

Hypertension (Dallas, Tex. : 1979)
ISSN: 1524-4563
Titre abrégé: Hypertension
Pays: United States
ID NLM: 7906255

Informations de publication

Date de publication:
12 2020
Historique:
pubmed: 20 10 2020
medline: 4 5 2021
entrez: 19 10 2020
Statut: ppublish

Résumé

Commensal gut microbiota are strongly correlated with host hemodynamic homeostasis but only broadly associated with cardiovascular health. This includes a general correspondence of quantitative and qualitative shifts in intestinal microbial communities found in hypertensive rat models and human patients. However, the mechanisms by which gut microbes contribute to the function of organs important for blood pressure (BP) control remain unanswered. To examine the direct effects of microbiota on BP, we conventionalized germ-free (GF) rats with specific pathogen-free rats for a short-term period of 10 days, which served as a model system to observe the dynamic responses when reconstituting the holobiome. The absence of microbiota in GF rats resulted with relative hypotension compared with their conventionalized counterparts, suggesting an obligatory role of microbiota in BP homeostasis. Hypotension observed in GF rats was accompanied by a marked reduction in vascular contractility. Both BP and vascular contractility were restored by the introduction of microbiota to GF rats, indicating that microbiota could impact BP through a vascular-dependent mechanism. This is further supported by the decrease in actin polymerization in arteries from GF rats. Improved vascular contractility in conventionalized GF rats, as indicated through stabilized actin filaments, was associated with an increase in cofilin phosphorylation. These data indicate that the vascular system senses the presence (or lack of) microbiota to maintain vascular tone via actin polymerization. Overall, these results constitute a fundamental discovery of the essential nature of microbiota in BP regulation.

Identifiants

pubmed: 33070663
doi: 10.1161/HYPERTENSIONAHA.120.15939
pmc: PMC7666075
mid: NIHMS1630391
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1847-1855

Subventions

Organisme : NCI NIH HHS
ID : R01 CA219144
Pays : United States
Organisme : NHLBI NIH HHS
ID : K99 HL151889
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL149762
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL143082
Pays : United States
Organisme : NIGMS NIH HHS
ID : R00 GM118885
Pays : United States

Références

Pharmacol Res. 2019 Mar;141:276-290
pubmed: 30639374
J Cell Biol. 1999 Dec 27;147(7):1519-32
pubmed: 10613909
Front Cell Infect Microbiol. 2019 May 08;9:148
pubmed: 31139578
Diabetes. 2019 Jul;68(7):1415-1426
pubmed: 31010956
Hypertension. 2019 Dec;74(6):1279-1293
pubmed: 31679421
Dis Model Mech. 2020 May 17;13(5):
pubmed: 32238420
J Hypertens. 2020 Feb;38(2):322-331
pubmed: 31584514
Compr Physiol. 2019 Sep 19;9(4):1305-1337
pubmed: 31688958
Am J Physiol Heart Circ Physiol. 2019 Jun 1;316(6):H1552-H1557
pubmed: 30978120
Nat Methods. 2010 May;7(5):335-6
pubmed: 20383131
J Am Coll Cardiol. 2019 Sep 10;74(10):1317-1328
pubmed: 31488269
Cardiovasc Res. 2013 Jun 1;98(3):428-36
pubmed: 23417038
J Am Heart Assoc. 2020 Jan 21;9(2):e014373
pubmed: 31928175
Transfusion. 2016 May;56(5):1138-47
pubmed: 26865079
Biochem Biophys Res Commun. 2018 Jul 2;501(4):1009-1015
pubmed: 29777703
J Am Coll Cardiol. 2018 Jan 16;71(2):109-118
pubmed: 29146532
Hypertension. 2015 Jun;65(6):1331-40
pubmed: 25870193
Physiol Genomics. 2015 Jun;47(6):187-97
pubmed: 25829393
PLoS One. 2019 Aug 23;14(8):e0221658
pubmed: 31442284
Mol Nutr Food Res. 2020 Apr;64(7):e1900390
pubmed: 31976617
J Mol Diagn. 2013 May;15(3):391-400
pubmed: 23541592
BMC Immunol. 2008 Nov 06;9:65
pubmed: 18990206
Microbiome. 2017 Feb 1;5(1):14
pubmed: 28143587
J Physiol. 2015 Jun 15;593(12):2547-9
pubmed: 26095019
Int J Mol Sci. 2020 May 17;21(10):
pubmed: 32429546
Am J Physiol. 1959 Dec;197:1345-6
pubmed: 13846013
Appl Environ Microbiol. 2006 Jul;72(7):5069-72
pubmed: 16820507
Physiol Genomics. 2017 Feb 1;49(2):96-104
pubmed: 28011881
J Hypertens. 2014 Mar;32(3):542-54
pubmed: 24309491
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Vascul Pharmacol. 2020 Feb - Mar;125-126:106633
pubmed: 31843471
Nature. 2020 Feb;578(7796):621-626
pubmed: 32051585
Cell Host Microbe. 2018 Jan 10;23(1):41-53.e4
pubmed: 29276170
Lancet. 2019 Aug 24;394(10199):639-651
pubmed: 31327564
J Res Med Sci. 2019 Dec 23;24:109
pubmed: 31949460
mBio. 2014 Jan 14;5(1):e00958-13
pubmed: 24425731
J Clin Microbiol. 2008 Jun;46(6):2129-32
pubmed: 18434561
Circ Res. 1977 Jul;41(1):19-26
pubmed: 862138
Hypertension. 2020 Jul;76(1):e1-e3
pubmed: 32426999

Auteurs

Bina Joe (B)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Cameron G McCarthy (CG)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Jonnelle M Edwards (JM)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Xi Cheng (X)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Saroj Chakraborty (S)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Tao Yang (T)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Rachel M Golonka (RM)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Blair Mell (B)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Ji-Youn Yeo (JY)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Nicole R Bearss (NR)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Janara Furtado (J)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Piu Saha (P)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Beng San Yeoh (BS)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Matam Vijay-Kumar (M)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Camilla F Wenceslau (CF)

From the UT Microbiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH